Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Invested Capital (2021 - 2025)

Verrica Pharmaceuticals has reported Invested Capital over the past 5 years, most recently at $24.7 million for Q4 2025.

  • Quarterly results put Invested Capital at $24.7 million for Q4 2025, up 17.14% from a year ago — trailing twelve months through Dec 2025 was $24.7 million (up 17.14% YoY), and the annual figure for FY2025 was $24.7 million, up 17.14%.
  • Invested Capital for Q4 2025 was $24.7 million at Verrica Pharmaceuticals, up from -$16.0 million in the prior quarter.
  • Over the last five years, Invested Capital for VRCA hit a ceiling of $102.5 million in Q1 2021 and a floor of -$16.0 million in Q3 2025.
  • Median Invested Capital over the past 5 years was $50.1 million (2022), compared with a mean of $48.0 million.
  • Biggest five-year swings in Invested Capital: surged 89.22% in 2023 and later tumbled 273.38% in 2025.
  • Verrica Pharmaceuticals' Invested Capital stood at $74.3 million in 2021, then crashed by 46.12% to $40.0 million in 2022, then soared by 56.46% to $62.6 million in 2023, then crashed by 66.28% to $21.1 million in 2024, then increased by 17.14% to $24.7 million in 2025.
  • The last three reported values for Invested Capital were $24.7 million (Q4 2025), -$16.0 million (Q3 2025), and $7.1 million (Q2 2025) per Business Quant data.